News Quantified

VTVT – vtv therapeutics inc. - class a (US:NASDAQ)

Stock Stats

News Stats

Order Stats

News

vTv Therapeutics Amends License Agreement with Newsoara Biopharma Co. Ltd. for PDE4 inhibitor, HPP737

vTv Therapeutics (NASDAQ:VTVT) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $49.00 price target on the stock, up previously from $40.00.

vTv Therapeutics (NASDAQ:VTVT) was upgraded by analysts at Roth Mkm to a "strong-buy" rating.

vTv Therapeutics (NASDAQ:VTVT) is now covered by analysts at Roth Mkm. They set a "buy" rating on the stock.

An Alzheimer's Drug Could Supercharge This High-Risk Stock. Is It Worth a Buy Here? [Yahoo! Finance]

-6.2%

MISS

Form 8-K vTv Therapeutics Inc. For: Jan 30

Form 8-K vTv Therapeutics Inc. For: Dec 19

Form SCHEDULE 13D/A vTv Therapeutics Inc. Filed by: Samsara BioCapital, L.P.

Form EFFECT vTv Therapeutics Inc.

Form SCHEDULE 13G/A vTv Therapeutics Inc. Filed by: Invus Global Management, LLC

Top News Gainers

2/7 vTv Therapeutics to Host Investor Call and Announce Results from Part 2 of the Phase 2 Simplici-T1 Study of TTP399 – Potential First-in-Class Oral Adjunctive Therapy for Patients with Type 1 Diabetes 52.4%

2/20 Q4/2019 12/31/2019 EPS -0.110 ZacksConsensus N/A ActVsEst N/A - N/A 15.5%

1/7 Form SC 13D/A vTv Therapeutics Inc. Filed by: MacAndrews & Forbes Inc. 15.3%

12/23 Form SC 13D/A vTv Therapeutics Inc. Filed by: MacAndrews & Forbes Inc. 13.4%

5/16 Form SC 13D/A vTv Therapeutics Inc. Filed by: MacAndrews & Forbes Inc. 13.0%

7/15 vTv Therapeutics to Present at 2019 Alzheimer’s Association International Conference 12.3%

9/11 Form 8-K vTv Therapeutics Inc. For: Sep 11 8.8%

1/28 Form 8-K vTv Therapeutics Inc. For: Jan 28 7.8%

8/16 vTv Therapeutics Inc (NASDAQ: VTVT) had its "buy" rating re-affirmed by analysts at HC Wainwright. 7.3%

9/4 Form 4 vTv Therapeutics Inc. For: Sep 04 Filed by: PERELMAN RONALD O 6.9%

Top News Decliners

3/11 Form 4 vTv Therapeutics Inc. For: Mar 10 Filed by: KINDLER JEFFREY B -21.6%

6/6 vTv Therapeutics Announces Positive Topline Results from Part 1 of the Phase 2 Simplici-T1 Trial in Patients with Type 1 Diabetes -18.9%

2/10 Vtv Therapeutics up 67% premarket on positive TTP399 data [Seeking Alpha] -16.7%

2/28 vTv Therapeutics Inc (NASDAQ: VTVT) was downgraded by analysts at ValuEngine from a "hold" rating to a "sell" rating. -9.0%

9/18 Form 4 vTv Therapeutics Inc. For: Sep 18 Filed by: PERELMAN RONALD O -8.1%

7/31 vTv Therapeutics Announces 2019 Second Quarter Financial Results and Update -7.7%

3/18 vTv Therapeutics Inc (NASDAQ: VTVT) had its "buy" rating re-affirmed by analysts at HC Wainwright. -6.9%

5/6 vTv Therapeutics Inc (NASDAQ: VTVT) was upgraded by analysts at Northland Securities from a "market perform" rating to an "outperform" rating. -6.8%

9/18 vTv Therapeutics Presents Additional Positive Data from the Phase 2 Simplici-T1 Study in Patients with Type 1 Diabetes at 55th Annual Meeting of the European Association for the Study of Diabetes -6.5%

5/30 vTv Therapeutics Inc (NASDAQ: VTVT) is now covered by analysts at HC Wainwright. They set a "buy" rating on the stock. -6.2%

Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies

If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.

Click Here To Register For The Live Online Workshop

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview

Earnings Week Wrap-up and Takeaways

Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix

Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More

The Smart Way to Ten Minutes Per Day